The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Ishita Drugs & Industries Ltd

Ishita Drugs & Industries Ltd

BSE 524400 · NSE ISHITADR · ISIN INE806D01016 · Group X · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹73.50

+1.80%

BSE close, 28 August 2026

Market cap

₹21.98 cr

0.3 cr shares · Micro cap

Free float

₹10.88 cr

as published

P/E · P/B

31.1× · 2.14×

EPS ₹2.36 · BV ₹34.35

FY25-26 rev / PAT

14.66 / 0.78

₹ cr, as filed

Filings, window

13

2 selected · 15%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹66.00 52-WK HIGH ₹90.85 ₹73.50 30% of range
Against 52-week high-19.1%
Against 52-week low+11.4%
Day change+1.80%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹2.36
Price / earnings31.14×
Price / book2.14×
Book value — derived, price ÷ P/B₹34.35
Return on equity6.88%
Operating margin11.29%
Net margin7.31%

Consistency check

P/B ÷ P/E, which must equal ROE
6.87%
ROE as published
6.88%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 3.15 0.23 0.77 11.29% 7.31%
Mar-26 · Q 3.06 0.18 0.59 10.25% 5.79%
FY25-26 14.66 0.78 2.60 8.45% 5.31%

Quarter on quarter

Revenue, quarter on quarter
+2.9%
Net profit, quarter on quarter
+27.8%
Operating margin, quarter on quarter
+104 bps

Disclosure profile 13 filings in the window

0 median 17.0 p75 · 25 sector max 52 13 34th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome1
Change in Management1
Selected sub-total2
Procedural
AGM / EGM4
Board Meeting2
General2
Annual Report1
Auditor Appointment1
Book Closure1
Procedural sub-total11
Total13

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group X, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

13 filings · 2 selected · busiest 2026-08-27

Filing rhythm · the twelve most recent

2026-08-272026-10-02

SelectedProcedural

Filings

13 in the window · 3 earlier on record

  1. 2 October 2026 ·

    Change in Management

    Change in Management

    1. Approval of re-appointment of Mrs. Abha Agrawal (DIN: 01589479) as a Non Executive Non-Independent Director of the Company post attaining the age of 75 years , and who retires by rotation, ....

    Company Update / Change in Management View filing →

  2. 2 October 2026 ·

    Auditor Appointment

    Appointment of Statutory Auditor/s

    Re-appointment of M/s. Jaymin Shah & Associates, Chartered Accountants (FRN: 129406W) as a statutory Auditor of the Company for the FY 2026-27.

    Company Update / Appointment of Statutory Auditor/s View filing →

  3. 2 October 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Disclosure of Voting Results and Scrutinizer's Report for 33rd Annual General Meeting of the Company held on Wednesday, 30th September, 2026.

    AGM/EGM / AGM View filing →

  4. 30 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Proceedings of the 33rd Annual General Meeting of the Company held on 30th September, 2026 at 11:30 A.M. and concluded on 12:30 P.M.

    AGM/EGM / AGM View filing →

  5. 22 September 2026 ·

    General

    Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Availing Credit Facilities From Bank

    Pursuant to the Regulation 30read with Schedule III of SEBI(LODR) Regulations, 2015, we wish to inform you that Ishita Drugs and Industries Limited has entred into loan agreement with HDFC ....

    Company Update / General View filing →

  6. 22 September 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Held On 22Nd September, 2026

    we wish to inform you that the Board of Directors of Ishita Drugs and Industries Limited, held its meeting today i.e. Tuesday, 22nd September, 2026, has, Approved the borrowings from the ....

    Board Meeting / Outcome of Board Meeting View filing →

  7. 18 September 2026 ·

    Board Meeting

    Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Ishita Drugs & Industries Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/09/2026 ,inter alia, to consider and approve 1. To consider and ....

    Board Meeting / Board Meeting View filing →

  8. 31 August 2026 ·

    General

    Weblink Intimation Letter To The Shareholders

    Company has issued letters providing a weblink of Company's website to access Annual report for Financial Year 2025-26 to those members who have not registered their email addresses.

    Company Update / General View filing →

  9. 27 August 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Annual Report for the Financial Year 2025-26 including Notice of 33rd Annual General Meeting of the Company to be held on 30.09.2026.

    Others / Reg. 34 (1) Annual Report View filing →

  10. 27 August 2026 ·

    AGM / EGM

    NOTICE OF 33RD ANNUAL GENERAL MEETING (AGM) ALONG WITH THE E-VOTING PERIOD

    Notice of 33RD AGM of the Company which will be held on wednesday, 30th September, 2026 and E voting period for AGM commence from 27.09.2026 (09:00 a.m. IST) and ends on 29.09.2026 (5:00 p.m. IST)

    AGM/EGM / AGM View filing →

  11. 27 August 2026 ·

    AGM / EGM

    INTIMATION OF E- VOTING AS PER THE REGULATION 44 OF SEBI (LODR) REGULATION, 2015

    The E-voting period for ensuing 33rd AGM which is to be held on 30.09.2026 will commence from 27.09.2026 (09:00 a.m. IST) and ends on 29.09.2026 (05:00 p.m. IST) (Both days inclusive).

    AGM/EGM / AGM View filing →

  12. 27 August 2026 ·

    Book Closure

    INTIMATION ABOUT THE BOOK CLOSURE FOR 33RD ANNUAL GENERAL MEETING (AGM)

    Register of Members and Share transfer book of the Company will remain closed from 24.09.2026 to 30.09.2026 (Both days Inc lusive) for the purpose of 33rd Annual General Meeting of the Company.

    Corp. Action / Book Closure View filing →

  13. 31 July 2026 ·

    Board Meeting

    Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (LODR) Regulations, 2015 For The Quarter Ended 30Th June, 2026.

    Ishita Drugs & Industries Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2026 ,inter alia, to consider and approve 1. To consider, approve ....

    Board Meeting / Board Meeting View filing →

RSS feed for Ishita Drugs & Industries Ltd · the 50 most recent filings